Mexico City. Vaccination against the coronavirus for adolescents between 12 and 17 years of age with some comorbidity began today throughout the country, although each entity will apply the biologics as people gather, because each vial contains ten doses and once thawed and opened it must be used in in its entirety, reported Hugo López-Gatell, Undersecretary of Prevention and Health Promotion
He indicated that until today 37 thousand adolescents have been registered with diseases such as type 1 diabetes, different types of cancer and asthma.
These and other serious conditions such as those that affect the heart, lungs, liver, digestive system, as well as neurological conditions (cerebral palsy, moderate or severe autism and difficult-to-control epilepsy, among others) increase the risk of serious complications and death. due to SARS-CoV-2 virus infection.
For this sector of the population, the vaccine developed by the Pfizer-Biontech laboratory alliance will be applied, the only one that until now has obtained the registration for its emergency use in individuals from 12 years of age.
Information from the Ministry of Health indicates that the biological showed safety and efficacy results of 75 percent after the first dose and 96 percent seven days after the second application.
–
– .
